Evidence map›Paper›PMID 32952829›Full record

ArticleThe Pan African medical journal2020

Dengue virus serological markers among potential blood donors: an evidence of asymptomatic dengue virus transmission in Cameroon.

Salomon Bonsi Tchuandom, Abel Lissom, Ghislaine Haverie Mimfoumou Ateba, Thibau Flaurant Tchouangueu, Constantin Tchakounte, Agbor Rolland Ayuk, Etienne Philemon Atabonkeng, Ankiambom Innocent Ngong, Godwin Nchinda, Jules-Roger Kuiate

Open access · goldAbstract read
In one paragraph

Article in The Pan African medical journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 2 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Salomon Bonsi TchuandomDepartment of Biochemistry, University of Dschang, Dschang, Cameroon.
Abel LissomLaboratory of Vaccinology/Biobanking, CIRCB, Melen-Yaoundé, Cameroon.
Ghislaine Haverie Mimfoumou AtebaBlood transfusion service, Yaounde Jamot Hospital, Yaoundé, Cameroon.
Thibau Flaurant TchouangueuDepartment of Biochemistry, University of Dschang, Dschang, Cameroon.
Constantin TchakounteDepartment of Biochemistry, University of Dschang, Dschang, Cameroon.
Agbor Rolland AyukNational Public Health Laboratory, Yaoundé, Cameroon.
Etienne Philemon AtabonkengDepartment of Biochemistry, University of Dschang, Dschang, Cameroon.
Ankiambom Innocent NgongPublic School of Medical Laboratory Technicians, Yaoundé, Cameroon.
Godwin NchindaLaboratory of Vaccinology/Biobanking, CIRCB, Melen-Yaoundé, Cameroon.
Jules-Roger KuiateDepartment of Biochemistry, University of Dschang, Dschang, Cameroon.
Université de Dschang · CMUniversité de Yaoundé I · CM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionthe risk of dengue virus or its antibodies which can be transmitted through blood transfusion by asymptomatic individuals infected, has been a major concern all over the world. Dengue is an endemic disease in sub-Saharan Africa, particularly in Cameroon. The purpose of this study is to determine the frequency of dengue virus (DENV) infection among potential blood donors at Yaounde Jamot Hospital.

methodsserum samples were collected from 310 potential adult blood donors aged 18-57 years, who signed a written informed consent and completed the questionnaire between March 2019 and August 2019. This serum is used to screen for the presence of serological markers of DENV infection (NS1, IgM and IgG) using immunochromatographic tests (Zhuhai Encode Medical Engineering Co., Ltd, China). IgM/IgG positive samples were confirmed by enzyme-linked immunosorbent assays (ELISA).

resultsthe overall prevalence was 24.8% among potential blood donors were subdivided as follows: 4.5% (14/310), 12.3% (38/310) and 6.1% (19/310) showed mono-positivity to DENV-NS1 antigen, anti-DENV IgM and anti-DENV IgG antibodies respectively. 1.9% (6/310) of potential blood donors showed dual positivity to anti-DENV IgM antibodies and anti-DENV IgG antibodies. The presence of DENV-NS1 antigen show asymptomatic viremia of dengue at the time of donation, while the presence of IgG antibodies reflects the high endemicity of dengue disease in the city of Yaoundé.

conclusionthese findings demonstrate the high level of risk of the DENV transmission among potential blood donors to needy recipients, underscoring the importance of establishing dengue fever blood screening in different services and blood collection units in Cameroon to improve safety transfusion and control the dissemination of the DENV.

Indexed as

Blood DonorsAdolescentAdultAntibodies, ViralCameroonCross-Sectional StudiesDengueDengue VirusEnzyme-Linked Immunosorbent AssayFemaleHumansImmunoglobulin GMaleMass ScreeningMiddle AgedSeroepidemiologic StudiesAntibodies, ViralImmunoglobulin GCameroonDengue feverpotential blood donorsseroprevalence

Identifiers

PMID32952829
PMCPMC7467628
OpenAlexW3042286557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.